Symbols / CERT Stock $6.12 +5.15% Certara, Inc.

Healthcare • Health Information Services • United States • NMS
CERT (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Mr. Jon Resnick
Exch · Country NMS · United States
Market Cap 952.06M
Enterprise Value 1.11B
Income -15.10M
Sales 419.75M
FCF (ttm) 116.57M
Book/sh 6.63
Cash/sh 0.96
Employees 1,515
Insider 10d —
IPO Dec 11, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E 14.81
PEG —
P/S 2.27
P/B 0.92
P/C —
EV/EBITDA 11.78
EV/Sales 2.64
Quick Ratio 1.78
Current Ratio 1.88
Debt/Eq 29.95
LT Debt/Eq —
EPS (ttm) -0.10
EPS next Y 0.41
EPS Growth —
Revenue Growth 0.90%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-06
Earnings (prior) 2026-05-11
ROA 0.75%
ROE -1.44%
ROIC —
Gross Margin 61.59%
Oper. Margin 3.80%
Profit Margin -3.60%
Shs Outstand 155.56M
Shs Float 107.30M
Insider Own 2.56%
Instit Own 112.53%
Short Float 25.18%
Short Ratio 7.65
Short Interest 25.28M
52W High 13.88
vs 52W High -55.91%
52W Low 4.45
vs 52W Low 37.53%
Beta 1.53
Impl. Vol. 12.50%
Rel Volume 0.81
Avg Volume 3.91M
Volume 3.18M
Target (mean) $7.62
Tgt Median $8.00
Tgt Low $6.00
Tgt High $10.00
# Analysts 11
Recom None
Prev Close $5.82
Price $6.12
Change 5.15%
About

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$7.62
Mean price target
2. Current target
$6.12
Latest analyst target
3. DCF / Fair value
$13.49
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$6.12
Low
$6.00
High
$10.00
Mean
$7.62

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-12 main Craig-Hallum Hold → Hold $8
2026-05-12 main BMO Capital Market Perform → Market Perform $6
2026-05-12 main Barclays Equal-Weight → Equal-Weight $7
2026-05-12 main Stephens & Co. Overweight → Overweight $9
2026-05-12 main Morgan Stanley Equal-Weight → Equal-Weight $10
2026-05-12 main Baird Neutral → Neutral $6
2026-04-13 main Keybanc Overweight → Overweight $8
2026-03-06 down Barclays Overweight → Equal-Weight $8
2026-02-27 main Barclays Overweight → Overweight $8
2026-01-08 main Keybanc Overweight → Overweight $12
2026-01-06 up Leerink Partners Market Perform → Outperform $13
2025-12-18 main Morgan Stanley Equal-Weight → Equal-Weight $12
2025-12-15 main Barclays Overweight → Overweight $13
2025-12-12 main Stephens & Co. Overweight → Overweight $12
2025-11-13 init BMO Capital — → Market Perform $9
2025-11-07 main Barclays Overweight → Overweight $14
2025-10-08 main Keybanc Overweight → Overweight $16
2025-10-02 main Barclays Overweight → Overweight $16
2025-09-29 init Craig-Hallum — → Buy $16
2025-08-07 main UBS Buy → Buy $15
News
RSS: Latest CERT news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-05-14 CASHMAN JAMES E III Chairman of the Board — 15,757 — —
2026-05-14 BROSHY ERAN Chairman of the Board — 15,757 — —
2026-05-14 WALSH MATTHEW M Director — 15,757 — —
2026-05-14 COLLINS CYNTHIA Director — 15,757 — —
2026-05-14 CRANE ROSEMARY A Director — 15,757 — —
2026-05-14 KILLEFER NANCY Director — 15,757 — —
2026-05-14 REYNDERS JOHN V W Chief Financial Officer — 15,757 — —
2026-05-14 BEDI ARJUN Director — 5,547 — —
2026-05-11 RESNICK JON MATTHEW Chief Executive Officer — 59,766 — —
2026-04-01 PEDERSEN LEIF E President — 33,167 — —
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
418.84
+8.75%
385.15
+8.70%
354.34
+5.57%
335.64
Operating Revenue
418.84
+8.75%
385.15
+8.70%
354.34
+5.57%
335.64
Cost Of Revenue
161.13
+4.28%
154.52
+9.57%
141.02
+6.37%
132.58
Reconciled Cost Of Revenue
142.52
+1.74%
140.08
+7.36%
130.48
+5.85%
123.27
Gross Profit
257.71
+11.74%
230.63
+8.12%
213.31
+5.05%
203.07
Operating Expense
236.70
+1.86%
232.36
+12.20%
207.10
+21.44%
170.55
Research And Development
41.04
+10.61%
37.10
+8.58%
34.17
+21.16%
28.20
Selling General And Administration
139.10
-1.81%
141.66
+11.19%
127.41
+28.46%
99.18
Selling And Marketing Expense
53.72
+13.23%
47.44
+48.16%
32.02
+16.83%
27.41
General And Administrative Expense
85.38
-9.38%
94.22
-1.22%
95.39
+32.90%
71.77
Other Gand A
85.38
-9.38%
94.22
-1.22%
95.39
+32.90%
71.77
Total Expenses
397.82
+2.83%
386.88
+11.13%
348.13
+14.85%
303.12
Operating Income
21.02
+1314.10%
-1.73
-127.87%
6.21
-80.90%
32.52
Total Operating Income As Reported
21.02
+1314.10%
-1.73
+95.75%
-40.77
-225.38%
32.52
EBITDA
102.52
+41.66%
72.37
+203.51%
23.84
-73.21%
89.00
Normalized EBITDA
102.52
+41.66%
72.37
+2.18%
70.83
-20.42%
89.00
Reconciled Depreciation
75.16
+10.48%
68.03
+21.33%
56.07
+6.86%
52.47
EBIT
27.35
+530.86%
4.34
+113.45%
-32.23
-188.23%
36.53
Total Unusual Items
0.00
0.00
+100.00%
-46.98
0.00
Total Unusual Items Excluding Goodwill
0.00
0.00
+100.00%
-46.98
0.00
Special Income Charges
0.00
0.00
+100.00%
-46.98
0.00
Impairment Of Capital Assets
0.00
0.00
-100.00%
46.98
0.00
Net Income
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Pretax Income
7.62
+144.32%
-17.18
+68.84%
-55.14
-394.02%
18.75
Net Non Operating Interest Income Expense
-19.74
+8.28%
-21.52
+6.09%
-22.92
-28.94%
-17.77
Interest Expense Non Operating
19.74
-8.28%
21.52
-6.09%
22.92
+28.94%
17.77
Net Interest Income
-19.74
+8.28%
-21.52
+6.09%
-22.92
-28.94%
-17.77
Interest Expense
19.74
-8.28%
21.52
-6.09%
22.92
+28.94%
17.77
Other Income Expense
6.34
+4.47%
6.07
+115.78%
-38.44
-1059.25%
4.01
Other Non Operating Income Expenses
6.34
+4.47%
6.07
-29.02%
8.55
+113.30%
4.01
Tax Provision
9.21
+279.45%
-5.13
-2498.60%
0.21
-94.68%
4.02
Tax Rate For Calcs
0.00
-29.77%
0.00
+42.38%
0.00
-2.14%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-9.87
0.00
Net Income Including Noncontrolling Interests
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Net Income From Continuing Operation Net Minority Interest
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Net Income From Continuing And Discontinued Operation
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Net Income Continuous Operations
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Normalized Income
-1.59
+86.76%
-12.05
+33.93%
-18.24
-223.82%
14.73
Net Income Common Stockholders
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Diluted EPS
-0.01
+87.50%
-0.08
+77.14%
-0.35
-488.89%
0.09
Basic EPS
-0.01
+87.50%
-0.08
+77.14%
-0.35
-488.89%
0.09
Basic Average Shares
160.39
+0.00%
160.39
+0.92%
158.94
+1.31%
156.88
Diluted Average Shares
160.39
+0.00%
160.39
+0.92%
158.94
-0.26%
159.35
Diluted NI Availto Com Stockholders
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Amortization
—
51.60
+17.34%
43.97
+6.14%
41.43
Amortization Of Intangibles Income Statement
—
51.60
+17.34%
43.97
+6.14%
41.43
Depreciation Amortization Depletion Income Statement
56.56
+5.53%
53.59
+17.72%
45.52
+5.48%
43.16
Depreciation And Amortization In Income Statement
56.56
+5.53%
53.59
+17.72%
45.52
+5.48%
43.16
Depreciation Income Statement
—
1.99
+28.48%
1.55
-10.34%
1.73
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,556.58
-1.18%
1,575.10
+0.77%
1,563.14
-0.62%
1,572.92
Current Assets
315.12
+1.37%
310.85
-8.63%
340.20
-0.60%
342.25
Cash Cash Equivalents And Short Term Investments
189.39
+5.70%
179.18
-23.74%
234.95
-0.69%
236.59
Cash And Cash Equivalents
189.39
+5.70%
179.18
-23.74%
234.95
-0.69%
236.59
Receivables
116.27
-2.37%
119.08
+27.70%
93.26
+5.01%
88.81
Accounts Receivable
94.56
+4.36%
90.61
+20.16%
75.41
+4.39%
72.24
Receivables Adjustments Allowances
-2.23
-3.28%
-2.16
-64.94%
-1.31
-4.96%
-1.25
Other Receivables
11.20
-18.48%
13.74
+27.74%
10.76
-7.22%
11.60
Taxes Receivable
12.74
-24.59%
16.89
+101.15%
8.40
+35.01%
6.22
Prepaid Assets
8.34
+0.24%
8.31
+30.68%
6.36
-24.15%
8.39
Restricted Cash
—
—
0.00
-100.00%
3.10
Hedging Assets Current
0.00
-100.00%
2.21
-50.53%
4.47
-3.56%
4.64
Other Current Assets
1.13
-45.21%
2.06
+77.63%
1.16
+58.20%
0.73
Total Non Current Assets
1,241.46
-1.80%
1,264.25
+3.38%
1,222.94
-0.63%
1,230.67
Net PPE
13.79
-13.84%
16.01
+30.42%
12.27
-27.06%
16.83
Gross PPE
19.50
-10.89%
21.88
+15.71%
18.91
-19.46%
23.47
Accumulated Depreciation
-5.70
+2.83%
-5.87
+11.50%
-6.63
+0.23%
-6.65
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
7.06
-0.07%
7.07
-12.81%
8.10
+5.22%
7.70
Other Properties
11.94
-13.74%
13.84
+44.12%
9.60
-33.43%
14.43
Leases
0.49
-48.97%
0.97
-19.03%
1.20
-10.93%
1.34
Goodwill And Other Intangible Assets
1,220.79
-1.73%
1,242.25
+3.23%
1,203.38
-0.10%
1,204.53
Goodwill
773.31
+2.15%
757.04
+5.68%
716.33
-0.20%
717.74
Other Intangible Assets
447.48
-7.78%
485.21
-0.38%
487.04
+0.05%
486.78
Non Current Deferred Assets
5.73
+26.28%
4.54
-3.24%
4.69
+5.75%
4.43
Non Current Deferred Taxes Assets
5.24
+32.34%
3.96
-6.49%
4.24
+14.39%
3.70
Non Current Prepaid Assets
1.16
-20.59%
1.46
+0.41%
1.45
+26.17%
1.15
Total Liabilities Net Minority Interest
493.79
-4.39%
516.45
+0.03%
516.30
+4.67%
493.26
Current Liabilities
153.38
+4.99%
146.09
+12.36%
130.02
+26.04%
103.16
Payables And Accrued Expenses
10.52
+53.11%
6.87
-44.81%
12.45
+4.33%
11.93
Payables
4.86
+23.47%
3.93
-36.39%
6.18
-36.64%
9.76
Accounts Payable
3.43
-2.17%
3.50
-32.28%
5.17
-31.36%
7.53
Current Accrued Expenses
5.66
+92.78%
2.94
-53.11%
6.26
+188.27%
2.17
Pensionand Other Post Retirement Benefit Plans Current
36.98
+19.10%
31.05
+8.46%
28.62
-3.03%
29.52
Total Tax Payable
1.43
+232.33%
0.43
-57.43%
1.01
-54.57%
2.22
Income Tax Payable
1.43
+232.33%
0.43
-57.43%
1.01
-54.57%
2.22
Current Debt And Capital Lease Obligation
7.42
-10.72%
8.31
+12.32%
7.39
-7.71%
8.01
Current Debt
2.96
-1.23%
3.00
-0.66%
3.02
+0.00%
3.02
Other Current Borrowings
2.96
-1.23%
3.00
-0.66%
3.02
+0.00%
3.02
Current Capital Lease Obligation
4.45
-16.08%
5.31
+21.28%
4.38
-12.38%
4.99
Current Deferred Liabilities
75.41
-3.11%
77.83
+28.27%
60.68
+16.22%
52.21
Current Deferred Revenue
75.41
-3.11%
77.83
+28.27%
60.68
+16.22%
52.21
Other Current Liabilities
23.07
+4.66%
22.04
+5.55%
20.88
+1302.35%
1.49
Total Non Current Liabilities Net Minority Interest
340.40
-8.09%
370.36
-4.12%
386.28
-0.98%
390.10
Long Term Debt And Capital Lease Obligation
298.57
-1.65%
303.59
+2.85%
295.17
-1.65%
300.12
Long Term Debt
290.13
-0.78%
292.43
+1.46%
288.22
-0.61%
289.99
Long Term Capital Lease Obligation
8.44
-24.43%
11.17
+60.55%
6.96
-31.36%
10.13
Non Current Deferred Liabilities
40.04
-7.28%
43.19
-20.43%
54.28
-22.65%
70.17
Non Current Deferred Revenue
2.35
+124.02%
1.05
-1.96%
1.07
-61.99%
2.81
Non Current Deferred Taxes Liabilities
37.69
-10.55%
42.14
-20.80%
53.21
-21.00%
67.35
Other Non Current Liabilities
—
23.58
-35.97%
36.83
+85.88%
19.81
Stockholders Equity
1,062.80
+0.39%
1,058.66
+1.13%
1,046.84
-3.04%
1,079.66
Common Stock Equity
1,062.80
+0.39%
1,058.66
+1.13%
1,046.84
-3.04%
1,079.66
Capital Stock
1.64
+1.30%
1.62
+1.06%
1.60
+0.44%
1.60
Common Stock
1.64
+1.30%
1.62
+1.06%
1.60
+0.44%
1.60
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
164.01
+1.26%
161.96
+1.04%
160.28
+0.38%
159.68
Ordinary Shares Number
159.14
-1.16%
161.01
+0.73%
159.85
+0.20%
159.53
Treasury Shares Number
4.87
+412.36%
0.95
+117.51%
0.44
+190.68%
0.15
Additional Paid In Capital
1,255.65
+3.18%
1,216.92
+3.26%
1,178.46
+2.46%
1,150.17
Retained Earnings
-129.88
-1.24%
-128.28
-10.37%
-116.23
-90.94%
-60.87
Gains Losses Not Affecting Retained Earnings
2.04
+115.20%
-13.42
-76.79%
-7.59
+7.74%
-8.23
Treasury Stock
66.66
+266.60%
18.18
+93.43%
9.40
+213.37%
3.00
Other Equity Adjustments
2.04
+115.20%
-13.42
-76.79%
-7.59
+7.74%
-8.23
Total Equity Gross Minority Interest
1,062.80
+0.39%
1,058.66
+1.13%
1,046.84
-3.04%
1,079.66
Total Capitalization
1,352.93
+0.14%
1,351.08
+1.20%
1,335.06
-2.53%
1,369.65
Working Capital
161.73
-1.84%
164.76
-21.61%
210.18
-12.09%
239.09
Invested Capital
1,355.89
+0.13%
1,354.08
+1.20%
1,338.08
-2.52%
1,372.67
Total Debt
305.99
-1.90%
311.90
+3.08%
302.57
-1.81%
308.13
Net Debt
103.70
-10.79%
116.24
+106.52%
56.29
-0.24%
56.42
Capital Lease Obligations
12.89
-21.74%
16.47
+45.38%
11.33
-25.10%
15.13
Net Tangible Assets
-157.99
+13.95%
-183.60
-17.29%
-156.54
-25.37%
-124.86
Tangible Book Value
-157.99
+13.95%
-183.60
-17.29%
-156.54
-25.37%
-124.86
Derivative Product Liabilities
1.79
0.00
—
—
Financial Assets
—
0.00
-100.00%
1.15
-69.19%
3.74
Interest Payable
0.05
+5.88%
0.05
-97.83%
2.35
+1235.80%
0.18
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
96.33
+19.71%
80.47
-2.77%
82.75
-10.58%
92.54
Cash Flow From Continuing Operating Activities
96.33
+19.71%
80.47
-2.77%
82.75
-10.58%
92.54
Net Income From Continuing Operations
-1.59
+86.76%
-12.05
+78.23%
-55.36
-475.79%
14.73
Depreciation Amortization Depletion
75.16
+10.48%
68.03
+21.33%
56.07
+6.86%
52.47
Depreciation
—
1.99
+28.48%
1.55
-10.34%
1.73
Amortization Cash Flow
—
66.04
+21.13%
54.52
+7.45%
50.74
Depreciation And Amortization
75.16
+10.48%
68.03
+21.33%
56.07
+6.86%
52.47
Amortization Of Intangibles
—
66.04
+21.13%
54.52
+7.45%
50.74
Other Non Cash Items
-4.05
-136.96%
10.97
-59.83%
27.31
+1498.13%
1.71
Stock Based Compensation
33.08
-4.87%
34.77
+22.88%
28.30
-6.74%
30.34
Provisionand Write Offof Assets
1.14
-21.86%
1.46
+114.04%
0.68
-36.19%
1.07
Asset Impairment Charge
0.00
0.00
-100.00%
46.98
0.00
Deferred Tax
-8.32
+34.45%
-12.70
+23.17%
-16.52
-43.54%
-11.51
Deferred Income Tax
-8.32
+34.45%
-12.70
+23.17%
-16.52
-43.54%
-11.51
Operating Gains Losses
—
—
0.07
-61.54%
0.17
Gain Loss On Investment Securities
—
—
—
—
Change In Working Capital
0.91
+109.08%
-10.03
-112.66%
-4.72
-226.54%
3.73
Change In Receivables
0.43
+102.64%
-16.23
-10774.34%
0.15
+101.01%
-15.01
Changes In Account Receivables
0.43
+102.64%
-16.23
-10774.34%
0.15
+101.01%
-15.01
Change In Prepaid Assets
-0.90
+68.60%
-2.87
-504.08%
0.71
+464.29%
0.13
Change In Payables And Accrued Expense
4.40
+192.40%
-4.76
+15.02%
-5.61
-161.75%
9.08
Change In Other Working Capital
-3.02
-121.82%
13.83
+49307.14%
0.03
-99.71%
9.53
Change In Other Current Liabilities
—
—
—
3.79
Investing Cash Flow
-26.56
+76.37%
-112.37
-41.25%
-79.55
-185.77%
-27.84
Cash Flow From Continuing Investing Activities
-26.56
+76.37%
-112.37
-41.25%
-79.55
-185.77%
-27.84
Capital Expenditure
-26.56
-26.21%
-21.04
-37.33%
-15.32
-22.29%
-12.53
Capital Expenditure Reported
-26.56
-26.21%
-21.04
-37.81%
-15.27
-21.86%
-12.53
Net Business Purchase And Sale
0.00
+100.00%
-91.33
-42.19%
-64.23
-319.57%
-15.31
Purchase Of Business
0.00
+100.00%
-91.33
-42.19%
-64.23
-319.57%
-15.31
Net Intangibles Purchase And Sale
0.00
0.00
+100.00%
-0.05
0.00
Purchase Of Intangibles
0.00
0.00
+100.00%
-0.05
0.00
Financing Cash Flow
-63.99
-204.55%
-21.01
-122.40%
-9.45
-28.30%
-7.36
Cash Flow From Continuing Financing Activities
-63.99
-204.55%
-21.01
-122.40%
-9.45
-28.30%
-7.36
Net Issuance Payments Of Debt
-2.99
-173.85%
4.05
+233.00%
-3.04
+8.09%
-3.31
Issuance Of Debt
0.00
-100.00%
6.30
0.00
0.00
Repayment Of Debt
-2.99
-32.64%
-2.25
+25.94%
-3.04
+8.09%
-3.31
Long Term Debt Issuance
0.00
-100.00%
6.30
0.00
0.00
Long Term Debt Payments
-2.99
-32.64%
-2.25
+25.94%
-3.04
+8.09%
-3.31
Net Long Term Debt Issuance
-2.99
-173.85%
4.05
+233.00%
-3.04
+8.09%
-3.31
Short Term Debt Issuance
—
—
—
0.00
Short Term Debt Payments
—
—
—
0.00
Net Short Term Debt Issuance
—
—
—
0.00
Net Common Stock Issuance
-42.61
0.00
0.00
0.00
Common Stock Payments
-42.61
0.00
0.00
0.00
Repurchase Of Capital Stock
-42.61
0.00
0.00
0.00
Net Other Financing Charges
-18.39
+26.64%
-25.06
-291.44%
-6.40
-58.07%
-4.05
Changes In Cash
5.78
+110.93%
-52.91
-747.68%
-6.24
-110.89%
57.34
Effect Of Exchange Rate Changes
4.43
+254.97%
-2.86
-289.77%
1.50
+135.17%
-4.28
Beginning Cash Position
179.18
-23.74%
234.95
-1.98%
239.69
+28.43%
186.62
End Cash Position
189.39
+5.70%
179.18
-23.74%
234.95
-1.98%
239.69
Free Cash Flow
69.77
+17.41%
59.42
-11.88%
67.43
-15.72%
80.01
Interest Paid Supplemental Data
19.13
-15.85%
22.74
+19.11%
19.09
+10.55%
17.27
Income Tax Paid Supplemental Data
12.22
-16.64%
14.66
-24.13%
19.32
+90.51%
10.14
Common Stock Issuance
—
—
0.00
0.00
Issuance Of Capital Stock
—
—
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category